10486 J. Am. Chem. Soc., Vol. 123, No. 43, 2001
Corbin et al.
of Illinois. Elemental analyses were also performed at the University
of Illinois School of Chemical Sciences.
(Rf ) 0.54, 10% hexane, 90% ethyl acetate) and recrystallized from
petroleum ether to give 7.80 g (81%) of the title compound as white
plates: mp 70-71 °C; 1H NMR (DMSO-d6) δ 9.07 (s, 1H, NH), 8.30
(s, 1H, butyl NH), 7.99 (d, J ) 5.0, 1H, H-6), 7.08 (s, 1H, H-3), 6.72
(d, J ) 5.0, 1H, H-5), 3.12 (m, 2H, CH2CH2CH2CH3), 2.21 (s, 3H,
Ar-CH3), 1.43 (m, 2H, CH2CH2CH2CH3), 1.29 (m, 2H, CH2CH2CH2-
CH3), 0.87 (t, J ) 7.3, 3H, CH3); 13C NMR (CD3CN) δ 156.84, 154.86,
150.79, 146.79, 119.04, 112.53, 39.98, 32.91, 21.18, 20.85, 14.08. Anal.
Calcd for C11H17N3O: C, 63.74; H, 8.27; N, 20.27. Found: C, 63.63;
H, 8.22; N, 20.47.
N,N′-Di-2-pyridylurea (1). A solution of triphosgene (940 mg, 3.20
mmol) in 10 mL of methylene chloride was added dropwise over 1 h
to a solution of 2-aminopyridine (1.50 g, 15.9 mmol) and 4-(dimethy-
lamino)pyridine (DMAP) (2.32 g, 19.0 mmol) in 15 mL of methylene
chloride. The resulting solution was stirred at room temperature for 27
h or until no starting material remained by TLC. Nitrogen was bubbled
through the reaction mixture to displace any unreacted phosgene, and
solvent was removed in vacuo. The crude product was purified by
column chromatography (Rf ) 0.59, ethyl acetate) and recrystallized
from ethyl acetate to provide 1.30 g (76%) of the product as white
needles. Crystals suitable for X-ray crystallographic analysis were
obtained from methanol by slow evaporation. Details of crystal structure
data and analysis were reported previously.9 mp 175-176 °C (lit.12
mp 175-176 °C); 1H NMR (DMSO-d6) δ 10.58 (s, 2H, NH), 8.27 (d,
J ) 5.2, 2H, H-6), 7.68-7.78 (m, 4H, H-3, H-4), 7.03 (m, 2H, H-5);
1H NMR (CDCl3, 23 mM, 50 °C) δ 10.14 (br s, 2H, NH), 8.38 (d, J
) 4.9, 2H, H-6), 7.68 (m, 2H, H-4), 7.55 (br s, 2H, H-3), 7.00 (m, 2H,
H-5); 13C NMR δ 153.63, 152.47, 147.15, 138.31, 118.18, 113.12; IR
(KBr, cm-1) 3223 (NH), 3142 (NH), 1698 (CdO); UV λmax (chloro-
form, nm) 280, 250. Anal. Calcd for C11H10N4O: C, 61.67; H, 4.70;
N, 26.15. Found: C, 61.61; H, 4.71; N, 26.18.
2-Pentanoylamido-1,8-naphthyridine (5). A mixture of 2-aminon-
aphthyridine (1.10 g, 7.90 mmol), valeric anhydride (25 mL), and
triethylamine (1 mL) was heated at 100 °C for 74 h or until no starting
material remained by TLC (Rf ) 0.44, 5% methanol/methylene
chloride). Excess valeric anhydride was removed by kugelrohr distil-
lation, and the resulting residue was dissolved in 5% methanol/95%
methylene chloride and passed through a short plug of silica. Solvent
was removed in vacuo, and the crude product was recrystallized twice
from ethyl acetate to give 680 mg (45%) of the title compound as a
1
cotton-like solid: mp 148-150 °C; H NMR (DMSO-d6) δ 11.06 (s,
1H, NH), 8.96 (dd, J6,7 ) 4.3, J5,7 ) 1.9, 1H, H-7), 8.40 (m, 2H, H-3,
H-4), 8.34 (dd, J5,6 ) 8.0, J5,7 ) 1.9, 1H, H-5), 7.48 (dd, J5,6 ) 8.0,
J6,7 ) 4.3, H-6), 2.45 (t, J ) 7.3, 2H, CH2CH2CH2CH3), 1.57 (m, 2H,
CH2CH2CH2CH3), 1.32 (m, 2H, CH2CH2CH2CH3), 0.88 (t, J ) 7.3,
3H, CH3); 13C NMR (DMSO-d6) δ 173.00, 154.82, 154.07, 153.65,
139.40, 136.55, 120.72, 120.53, 115.67, 37.47, 27.22, 22.17, 13.66.
Anal. Calcd for C13H15N3O: C, 68.10; H, 6.59; N, 18.33. Found: C,
68.12; H, 6.67; N, 18.55.
2,7-Dipentanoylamido-1,8-naphthyridine (2). A mixture of di-
aminonaphthyridine 13 (1.18 g, 7.38 mmol), valeric anhydride (15 mL),
and triethylamine (1.80 mL, 12.9 mmol) was heated at 100 °C for 24
h or until no starting material remained by TLC. The resulting mixture
was cooled to room temperature, and excess valeric anhydride was
removed by kugelrohr distillation. The crude material was dissolved
in 100 mL of methylene chloride and washed twice with 40 mL of
water, twice with 40 mL of a saturated aqueous solution of sodium
bicarbonate, and once with 30 mL of water. The organic solution was
dried over sodium sulfate, filtered, and solvent was removed in vacuo.
The crude product was purified by column chromatography (Rf ) 0.80,
50% ethyl acetate, 50% methylene chloride) and recrystallized twice
from ethyl acetate to give 640 mg (30%) of 2 as large white plates:
Bis-2,7-(3-(3,4,5-tridodecyloxyphenyl)uryl)-1,8-naphthyridine (6).
A solution of azide 20 (754 mg, 1.08 mmol) in 10 mL of toluene was
heated at 90-110 °C for 1 h. The resulting solution was cooled to
room temperature, and solvent was removed in vacuo. The crude
isocyanate 21 was used in the next step without further purification:
1H NMR δ 6.29 (s, 2H, H-2, H-6), 3.92 (m, 6H, OCH2), 2.77 (m, 2H,
OCH2CH2-4), 1.81 (m, 4H, OCH2CH2-3,5), 1.47 (m, 6H, CH2), 1.28
(m, 48H, CH2), 0.90 (m, 9H, CH3); IR (Nujol, cm-1) 2263 (NdCdO).
A mixture of isocyanate 21 (720 mg, 1.07 mmol) and naphthyridine
13 (67 mg, 0.51 mmol) in 250 µL of N,N-dimethylformamide (DMF)
and triethylamine was heated at 80 °C overnight. The resulting solution
was cooled to room temperature, and solvent was removed in vacuo.
The crude product was purified by radial chromatography (0-10%
gradient of methanol/methylene chloride) to give 275 mg (34% yield
for the two steps) of 6 as a yellow powder: mp 223 °C (dec); TLC (Rf
1
mp 216-217 °C; H NMR δ 9.25 (s, 2H, NH), 8.45 (d, J ) 8.8, 2H,
H-4, H-5), 8.06 (d, J ) 8.8, 2H, H-3, H-6), 2.43 (t, J ) 7.4, 4H, CH2-
CH2CH2CH3), 1.65 (m, 4H, CH2CH2CH2CH3), 1.32 (m, 4H, CH2-
CH2CH2CH3), 0.88 (t, J ) 7.5, 6H, CH3); 13C NMR δ 172.64, 154.09,
153.40, 138.99, 118.17, 113.58, 37.54, 27.23, 22.20, 13.70; MS (EI,
70 eV) m/z 328 (M+, 5.3), 299 (32.5), 160 (100); HRMS calcd for
C18H24N4O2, 328.1899; found, 328.1900. Anal. Calcd for C18H24N4O2:
C, 65.83; H, 7.37; N, 17.06. Found: C, 65.95; H, 7.22; N, 17.11.
N-Butyl-N′-(1,8-naphthyridin-2-yl)urea (3). A solution of 2-amino-
1,8-naphthyridine (1.00 g, 6.90 mmol) and butylisocyanate (800 µL,
7.20 mmol) in 60 mL of THF was heated at reflux for 15 h or until no
starting material remained by TLC. The suspension was cooled to room
temperature, and the solid that formed was collected by vacuum
filtration and recrystallized twice from methanol to give 1.05 g (68%)
of the title compound as yellow prisms. Crystals suitable for X-ray
crystallographic analysis were obtained from methanol by slow
evaporation. Details of crystal structure data and analysis are provided
1
) 0.20, 10% methanol, 90% methylene chloride); H NMR (CDCl3,
15 mM) δ 12.50 (s, 2H, NH-1), 9.81 (s, 2H, NH-2), 7.95 (d, J ) 7.9,
2H, H-4, H-5), 7.08 (d, J ) 7.9, 2H, H-3, H-6), 6.89 (s, 4H, H-2′,
H-6′), 3.92 (t, J ) 6.3, 4H, OCH2-4′), 3.66 (t, J ) 5.5, 8H, OCH2-
3′,5′), 1.70 (m, 12H, OCH2CH2-3′,4′,5′), 1.49 (m, 4H, OCH2CH2CH2-
4′), 1.30 (m, 104H, CH2), 0.82 (m, 18H, CH3); 13C NMR δ 155.06,
153.55, 153.32, 152.12, 138.54, 134.47, 133.28, 114.52, 119.92, 98.38,
73.44, 68.45, 31.97, 31.92, 30.58, 29.91, 19.88, 29.87, 29.86, 29.78,
29.72, 29.65, 29.50, 29.45, 29.40, 26.30, 26.19, 22.70, 22.68, 14.08;
IR (KBr, cm-1) 3220 (NH), 3142 (NH), 1690 (CdO). Anal. Calcd for
C99H162N6O8: C, 75.07; H, 10.85; N, 5.59. Found: C, 75.07; H, 10.82;
N, 5.77.
1
as Supporting Information. mp 196-197 °C; H NMR (DMSO-d6) δ
9.91 (s, 1H, NH adjacent to heterocycle), 9.54 (s, 1H, butyl NH), 8.86
(dd, J6,7 ) 4.4, J5,7 ) 1.8, 1H, H-7), 8.24-8.27 (m, 2H, H-4, H-5),
7.42 (dd, J5,6 ) 8.0, J6,7 ) 4.4, 1H, H-6), 7.33 (d, J3,4 ) 8.8, 1H, H-3),
3.27 (t, J ) 7.3, 2H, CH2CH2CH2CH3), 1.51 (m, 2H, CH2CH2CH2-
N,N′-Di-((5,7-dipropyl-(1,8-naphthyridin))-2-yl)urea (7). A solu-
tion of triphosgene (51 mg, 0.17 mmol) in 10 mL of methylene chloride
was added dropwise over 1 h to a solution of aminonaphthyridine 25
(200 mg, 0.87 mmol) and DMAP (127 mg, 1.04 mmol) in 15 mL of
methylene chloride. The resulting mixture was stirred at room tem-
perature for 24 h or until no starting material remained by TLC.
Nitrogen was bubbled through the reaction mixture to displace any
unreacted phosgene, and solvent was removed in vacuo. The crude
product was purified by column chromatography (Rf ) 0.41, 5%
methanol, 95% methylene chloride) and recrystallized from ethyl acetate
to give 67 mg (32%) of the title compound as a white solid: mp 239-
CH3), 1.38 (m, 2H, CH2CH2CH2CH3), 0.91 (t, J ) 7.3, 3H, CH3); 13
C
NMR (DMSO-d6) δ 155.70, 155.00, 154.36, 153.48, 139.73, 137.43,
120.63, 118.92, 114.80, 32.12, 31.14, 20.10, 14.10; IR (Nujol, cm-1
)
3220 (NH), 3125 (NH), 1690 (CdO). Anal. Calcd for C13H16N4O: C,
63.92; H, 6.60; N, 22.93. Found: C, 63.94; H, 6.80; N, 23.03.
N-Butyl-N′-(4-methylpyridin-2-yl)urea (4). A mixture of 2-amino-
4-methylpyridine (5.00 g, 46.3 mmol) and butylisocyanate (6.80 mL,
60.4 mmol) in 125 mL of THF was heated at reflux for 24 h or until
no starting material remained by TLC. The resulting mixture was cooled
to room temperature, and solvent and excess isocyanate were removed
in vacuo. The oily material obtained was triturated with low-boiling
petroleum ether, which prompted precipitation of the product. The solid
was collected by vacuum filtration, purified by column chromatography
1
241 °C; H NMR (DMSO-d6) δ 11.32 (s, 2H, NH), 8.56 (d, J ) 9.1,
2H, H-4), 7.92 (br s, 2H, H-3), 7.25 (s, 2H, H-6), 3.00 (t, J ) 7.6, 4H,
CH2), 2.88 (t, J ) 7.3, 4H, CH2), 1.81 (m, 4H, CH2), 1.67 (m, 4H,
CH2), 0.95 (m, 12H, CH3); 13C NMR (DMSO-d6) δ 165.63, 154.34,
153.68, 152.23, 149.70, 136.01, 120.39, 116.88, 113.32, 40.24, 32.68,